Drug
Monosialotetrahexosylganglioside clinical trials
Includes 2 studies of Monosialotetrahexosylganglioside sodium.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Sun Yat-sen University (2) · Tianjin Medical University Cancer Institute and Hospital (2) · Alliance for Clinical Trials in Oncology (1) · Yuhong Li (1)
Studies
Open first, then newest update. How each study uses Monosialotetrahexosylganglioside is read from its arms, and is right about nine times in ten.
Testing it · 6
- Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With PaclitaxelActive, not recruitingPhase 2Alliance for Clinical Trials in OncologyNCT05751668Written as Monosialotetrahexosylganglioside
- GM1 Prophylaxis for WBRT Related Cognitive DysfunctionTerminatedPhase 3Sun Yat-sen UniversityNCT04395339Written as Monosialotetrahexosyl ganglioside (GM1)
- Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal CancerCompletedPhase 3Yuhong LiNCT02251977Written as GM1
- Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRCStatus unknownPhase 3Tianjin Medical University Cancer Institute and HospitalNCT02024412Written as monosialotetrahexosylganglioside Sodium
- Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric CancerStatus unknownPhase 3Tianjin Medical University Cancer Institute and HospitalNCT02024438Written as monosialotetrahexosylganglioside Sodium
- Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral NeuropathyStatus unknownPhase 2Sun Yat-sen UniversityNCT02093910Written as Monosialotetrahexosylganglioside